What is the current state of pramlintide in the market

The substance (medicine Symlin, pramlintide acetate, produced by Amylin Works) has passed the phase III clinical studies and has been administered to a total of 4,800 individuals so far. In the year 2000, an application was submitted to the FDA to allow its promotion in the market but the FDA asked for more explanatory data in the following years. In March 2005 its circulation was approved in the USA as an adjunct treatment for Type 1 and 2 diabetics on insulin who have failed to achieve glycaemic control.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment